STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — SpringWorks Therapeutics Inc. (SWTX) on Tuesday reported a loss of $53.5 million in its third quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 72 cents.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The biopharmaceutical company posted revenue of $49.3 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $53.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SWTX at https://www.zacks.com/ap/SWTX